Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
This review illustrates the recent understanding of amyloid-β oligomers' characteristics and toxicity-related pathways, along with inhibitors against Aβ aggregation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ plaques are accumulations of sticky Aβ peptides outside of the neurons and impede the synaptic communication between neurons, leading to neuronal death.”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Aβ peptides are formed by proteolytic cleavage of the amyloid precursor protein (APP), specifically the hydrophobic transmembrane portion, by β- and γ-secretases [3].”
From Primary Cilia and Cardiovascular Risk Factors in Alzheimer's Disease (2025) · cites this paper as [3]
In the citing paper
“Soluble Aβ oligomers are the primary neurotoxic substances,131–133”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [133]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAlzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 101–200 of 577
Li, Q., Yu, X., Li, X., Bao, L., Zhang, Y., Wang, S., Jiang, M., Huang, K., & Xu, L. (2023) · Small · doi:10.1002/smll.202205634 · Cited by 47
Sun, L., Sharma, A. K., Han, B.-H., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00376 · Cited by 51
Metabolite assemblies: A surprising extension to the amyloid hypothesis
Gour, N., & Gazit, E. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.07.005 · Cited by 48
Zhou, C., Chao, F., Zhang, Y., Jiang, L., Zhang, L., Fan, J., Wu, Y., Dou, X., & Tang, Y. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24616 · Cited by 44
Liu, H., Qian, C., Yang, T., Wang, Y., Luo, J. H., Zhang, C., Wang, X., Wang, X., & Guo, Z. (2020) · Chemical Science · doi:10.1039/d0sc00392a · Cited by 45
Li, Y., Tang, H., Zhu, H., Käkinen, A., Wang, D., Andrikopoulos, N., Sun, Y., Nandakumar, A., Kwak, E., Davis, T. P., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06478 · Cited by 46
Wall, B. J., Will, M. F., Yawson, G. K., Bothwell, P. J., Platt, D. C., Apuzzo, C. F., Jones, M. A., Ferrence, G. M., & Webb, M. I. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00360 · Cited by 44
Hu, S., Yang, C., Li, Y., Luo, Q., & Luo, H. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113881 · Cited by 48
Zhang, L., Cao, K., Xie, J., Liang, X., Gong, H., Luo, Q., & Luo, H. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02543-z · Cited by 53
“Although the exact role of Aβ 42 aggregates in AD pathogenesis is unclear, most Aβ 42 species are neurotoxic and lead to neuronal dysfunction and death [6–9].”
BackgroundNatural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
Huang, J., Huang, N., Mao, Q., Shi, J., & Qiu, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1130253 · Cited by 45
“Aβ is a product of amyloid precursor protein (APP) and is degraded or cleared by an insulindegrading enzyme (IDE) (Lee et al., 2017; Díaz et al., 2022; Imbimbo et al., 2023).”
BackgroundFluid biomarkers for the diagnosis of neurodegenerative diseases
Luebke, M., Parulekar, M. S., & Thomas, F. P. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100062 · Cited by 45
Buchanan, J. A., Varghese, N., Johnston, C. L., & Sunde, M. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167919 · Cited by 36
BODIPY Dyes as Probes and Sensors to Study Amyloid-β-Related Processes
Dzyuba, S. V. (2020) · Biosensors · doi:10.3390/bios10120192 · Cited by 45
Paul, P. S., Cho, J., Wu, Q., Karthivashan, G., Grabovac, E., Wille, H., Kulka, M., & Kar, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01269-0 · Cited by 43
“The extended β-sheet promotes Aβ oligomer formation which serves as nuclei for fibril growth and subsequent deposition of Aβ aggregates in neuritic plaques of AD brains [10, 11].”
BackgroundAnand, B. G., Wu, Q., Karthivashan, G., Shejale, K. P., Amidian, S., Wille, H., & Kar, S. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.029 · Cited by 48
Gehlot, P., Kumar, S., Vyas, V. K., Choudhary, B. S., Sharma, M., & Malik, R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117047 · Cited by 46
Liu, H., Zhou, X., Shen, Q. P., & Xing, D. (2018) · Theranostics · doi:10.7150/thno.23483 · Cited by 41
Designed Polymer Micelle for Clearing Amyloid Protein Aggregates via Up-Regulated Autophagy
Debnath, K., Jana, N. R., & Jana, N. R. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01196 · Cited by 39
High‐affinity multivalent interactions between apolipoprotein E and the oligomers of amyloid‐β
Ghosh, S., Sil, T. B., Dolai, S., & Garai, K. (2019) · FEBS Journal · doi:10.1111/febs.14988 · Cited by 42
Molecular simulations of amyloid beta assemblies
Grasso, G., & Danani, A. (2020) · Advances in Physics X · doi:10.1080/23746149.2020.1770627 · Cited by 49
Yin, Z., Geng, X., Zhang, Z., Wang, Y., & Gao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746711 · Cited by 40
“The latest β-amyloid cascade hypothesis suggests that Aβ in the oligomeric form is the earliest culprit of AD (Lacor et al., 2004; Staderini et al., 2015; Lee et al., 2017).”
BackgroundThe Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases
Liu, N., Lin, M., & Wang, Y. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03063-3 · Cited by 43
Modulating protein amyloid aggregation with nanomaterials
Wang, B., Pilkington, E. H., Sun, Y., Davis, T. P., Ke, P. C., & Ding, F. (2017) · Environmental Science Nano · doi:10.1039/c7en00436b · Cited by 50
Ganglioside-Mediated Assembly of Amyloid β-Protein: Roles in Alzheimer's Disease
Matsuzaki, K., Kato, K., & Yanagisawa, K. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.005 · Cited by 39
Quercetin Encapsulated Polymer Nanoparticle for Inhibiting Intracellular Polyglutamine Aggregation
Debnath, K., Jana, N. R., & Jana, N. R. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00518 · Cited by 40
Pan, J., He, R., Huo, Q., Shi, Y., & Zhao, L. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03076-1 · Cited by 45
Wallin, C., Friedemann, M., Sholts, S. B., Noormägi, A., Svantesson, T., Jarvet, J., Roos, P. M., Palumaa, P., Gräslund, A., & Wärmländer, S. K. T. S. (2019) · Biomolecules · doi:10.3390/biom10010044 · Cited by 42
Han, J., Lee, H. J., Kim, K. Y., Nam, G., Chae, J., & Lim, M. H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916944117 · Cited by 37
Self-citationSingh, A., Ujjwal, R. R., Naqvi, S., Verma, R. K., Tiwari, S., Kesharwani, P., & Shukla, R. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2063297 · Cited by 39
“In AD, production of the Ab in brain higher compared to the clearance rate results in deposition of aggregates at extra neuronal sites [2].”
BackgroundYin, Z., Zhang, Z., Gao, D., Luo, G., Ma, T., Wang, Y., Lu, L., & Gao, X. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18060 · Cited by 40
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers
Bisceglia, F., Natalello, A., Serafini, M. M., Colombo, R., Verga, L., Lanni, C., & Lorenzi, E. D. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.062 · Cited by 38
Mandal, S., Debnath, K., Jana, N. R., & Jana, N. R. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00143 · Cited by 38
Dalès, J.-P., & Desplat‐Jégo, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239105 · Cited by 36
“In these lesions, copper–amyloid complexes are expected to catalyze the production of ROS involved in neuronal death [88,89].”
BackgroundCoskuner‐Weber, O., & Uversky, V. N. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.007 · Cited by 36
Wei, Z., Dong, X., & Sun, Y. (2024) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2024.113907 · Cited by 36
Application of carbon-based nanomaterials in Alzheimer's disease
Bai, M., Shao, X., Wang, C., Wang, J., Wang, X., Guan, P., & Hu, X. (2024) · Materials Horizons · doi:10.1039/d4mh01256a · Cited by 38
Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation
Windsor, P. K., Plassmeyer, S. P., Mattock, D. S., Bradfield, J. C., Choi, E. Y., Miller, B. R., & Han, B. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062888 · Cited by 37
“stress by disrupting cell membrane integrity, signal transduction, and other key homeostatic mechanisms [7].”
BackgroundLiu, S., Li, S., Lin, J., Li, J., & Yang, H. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00287 · Cited by 37
Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease
Żukowska, J., Moss, S. J., Subramanian, V., & Acharya, K. R. (2023) · FEBS Journal · doi:10.1111/febs.16939 · Cited by 44
“Further complexity is also present when considering that oligomers will be formed in both intra-and extracellular environments [72].”
The relationship between hypoxia and Alzheimer’s disease: an updated review
Tao, B., Gong, W., Xu, C., Ma, Z., Mei, J., & Chen, M. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1402774 · Cited by 42
“Structured oligomers among different A β species are suggested to be more toxic than fibrils and the identification of A β oligomers has proven challenging due to their diversity and instability (Lee et al., 2017).”
BackgroundStructural analysis of copper(I) interaction with amyloid β peptide
Gregorio, G. D., Biasotto, F., Hecel, A., Łuczkowski, M., Kozłowski, H., & Valensin, D. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.03.006 · Cited by 38
Yu, H., Zhao, W., Xie, M., Li, X., Sun, M. B., He, J. H., Wang, L., & Yu, L. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03566 · Cited by 35
Rana, M., Cho, H., Arya, H., Bhatt, T. K., Bhar, K., Bhatt, S., Mirica, L. M., & Sharma, A. K. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00502 · Cited by 34
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Cheng, G., Xie, A., Yan, Z., Zhu, X., Song, Y., & Chen, T. (2023) · Brain‐X · doi:10.1002/brx2.27 · Cited by 37
New horizons in the diagnosis and management of Alzheimer’s Disease in older adults
Dolphin, H., Dyer, A. H., Morrison, L., Shenkin, S. D., Welsh, T. J., & Kennelly, S. (2024) · Age and Ageing · doi:10.1093/ageing/afae005 · Cited by 37
“The most toxic of these is amyloid-β 42 (A β -42) which is released back into the extracellular space and causes a conformational change in other amyloid proteins that aggregate into oligomers, fibrils and ultimately plaques [9].”
BackgroundElastic moduli of biological fibers in a coarse-grained model: crystalline cellulose and β-amyloids
Poma, A. B., Chwastyk, M., & Cieplak, M. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp05269c · Cited by 33
Prenylated Curcumin Analogues as Multipotent Tools To Tackle Alzheimer’s Disease
Bisceglia, F., Seghetti, F., Serra, M., Zusso, M., Gervasoni, S. I., Verga, L., Vistoli, G., Lanni, C., Catanzaro, M., Lorenzi, E. D., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00463 · Cited by 35
“As a consequence, it is clear that more than one technique has to be used, since a potential inhibitor of the oligomerization may not be identified by using a specific assay for fibrils 14 .”
InfluentialYao, L., Zhou, Z., Wang, S., Zou, Q., Wang, H., Ma, L., Wang, S., & Zhang, X. (2022) · Chemical Science · doi:10.1039/d2sc00253a · Cited by 34
“2 – 5 The mainstream viewpoint holds that soluble and structured A b oligomers and mature amyloid brils are crucial to the onset and progression of AD, 6 – 8 which lead to disturbing the neural function and apoptosis of neurons.”
Kang, J., Nam, J. S., Lee, H. J., Nam, G., Rhee, H., Kwon, T., & Lim, M. H. (2019) · Chemical Science · doi:10.1039/c9sc00931k · Cited by 32
Self-citationGeng, H., Yuan, H., Qiu, L., Gao, D. M., Cheng, Y., & Xing, C. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01863e · Cited by 31
Laser Emission of Thioflavin T Uncovers Protein Aggregation in Amyloid Nucleation Phase
Hańczyc, P., & Fita, P. (2021) · ACS Photonics · doi:10.1021/acsphotonics.1c00082 · Cited by 34
Yang, W., Xu, Q., Yuan, Q., Xian, Y., & Lin, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109504 · Cited by 34
Watanabe‐Nakayama, T., Tsuji, M., Umeda, K., Oguchi, T., Konno, H., Noguchi‐Shinohara, M., Kiuchi, Y., Kodera, N., Teplow, D. B., & Ono, K. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00187 · Cited by 32
Sahoo, B. R., Bekier, M. E., Liu, Z., Kocman, V., Stoddard, A. K., Anantharamaiah, G. M., Nowick, J. S., Fierke, C. A., Wang, Y., & Ramamoorthy, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.005 · Cited by 30
“While there is significant interest in fully characterizing Aβ oligomers due to their roles in the pathogenesis of AD [6], several studies have shown the co-occurrence of other cellular cofactors including proteins [7], such as apolipoprotein fragments in the formation of heterooligomers [8].”
BackgroundVariable Mutations at the p53-R273 Oncogenic Hotspot Position Leads to Altered Properties
Garg, A., Hazra, J. P., Sannigrahi, M. K., Rakshit, S., & Sinha, S. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.12.015 · Cited by 32
Yan, C., Zhang, N., Guan, P., Chen, P., Ding, S., Hou, T., Hu, X., Wang, J., & Wang, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.03.061 · Cited by 31
Duan, Y., Chen, J., Jin, Y., Tu, Q., Wang, S., & Xiang, J. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c05281 · Cited by 31
Leng, H., Wang, Y., Wang, J., Sun, H., Sun, A., Pistolozzi, M., Zhang, L., & Yan, J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03452 · Cited by 31
Song, C., Zhang, T., & Zhang, Y. (2022) · Molecules · doi:10.3390/molecules27196751 · Cited by 34
“An increasing number of studies have demonstrated that in addition to directly destroying the integrity and permeability of neuronal cell membranes by forming membrane pores [12–14], extracellular Aβ42Os are mainly capable of binding to a variety of membrane receptors or membrane proteins on the surface of neural cell…”
BackgroundPolyoxometalates: metallodrug agents for combating amyloid aggregation
Ma, M., Liu, Z., Zhao, H., Zhang, H., Ren, J., & Qu, X. (2024) · National Science Review · doi:10.1093/nsr/nwae226 · Cited by 31
“…remains unclear, the mainstream belief now is that the widespread accumulation of A β peptide in the brain is an initial and pivotal event in the progression of AD, further eliciting a series of detrimental cascades, including tau pathology, chronic inflammation, and cognitive mal-function [4 –7 ].”
BackgroundLi, Y., Awasthi, S., Bryan, L. C., Ehrlich, R. S., Tonali, N., Balog, S., Yang, J., Sewald, N., & Mayer, M. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00097 · Cited by 31
Lieblein, T., Zangl, R., Martin, J., Hoffmann, J., Hutchison, M.-T., Stark, T., Stirnal, E., Schrader, T. H., Schwalbe, H., & Morgner, N. (2020) · eLife · doi:10.7554/elife.59306 · Cited by 31
“The cause of onset and progression of AD is unknown, but evidence points to the increased formation of oligomers of the neurotoxic amyloid-b peptide (Ab42) playing a major role in the development of AD (Hamley, 2012; Anand et al., 2014; Bu et al., 2016; Defelice and Ferreira, 2002; Gilbert, 2014; Lee et al., 2017; Zha…”
BackgroundSulfobutylether-β-Cyclodextrin for Inhibition and Rupture of Amyloid Fibrils
Shinde, M. N., Khurana, R., Barooah, N., Bhasikuttan, A. C., & Mohanty, J. (2017) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.7b07286 · Cited by 30
Han, J., Lee, H. J., Kim, K. Y., Lee, S. J. C., Suh, J., Cho, J., Chae, J., & Lim, M. H. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00454 · Cited by 32
Self-citationWang, Y., Wu, Q., Anand, B. G., Karthivashan, G., Phukan, G., Yang, J., Thinakaran, G., Westaway, D. A., & Kar, S. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12647 · Cited by 33
Post-Translational Modifications of BACE1 in Alzheimer's Disease
Wen, W., Li, P., Liu, P., Xu, S., Wang, F., & Huang, J. H. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210121163224 · Cited by 36
Mann, S., Kaur, A., Kaur, A., Priyadarshi, N., Goyal, B., Singhal, N. K., & Goyal, D. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00041 · Cited by 28
Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies
Bigi, A., Loffredo, G., Cascella, R., & Cecchi, C. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109093848 · Cited by 29
Reproducibility Problems of Amyloid-β Self-Assembly and How to Deal With Them
Faller, P., & Hureau, C. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2020.611227 · Cited by 36
“Oligomers are now regarded as the most toxic species rather than fibrils (Hayden and Teplow, 2013; Lee et al., 2017; Rana and Sharma, 2019).”
BackgroundZhang, Y., Ding, C., Li, C., & Wang, X. (2021) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.08.008 · Cited by 29
Xu, Q., Su, Z., Hu, Z. J., Yang, W., Xian, Y., & Lin, Z. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154441 · Cited by 34
Animal models of Alzheimer’s disease: preclinical insights and challenges
Xu, Q., Yang, W., Zhong, M., Lin, Z., Gray, N. E., & Xian, Y. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0001 · Cited by 44
“6 Aβ infusion (single or chronic) The amyloid cascade hypothesis proposes that cerebral accumulation and aggregation of Aβ in the initial stage of AD is the primary culprit driving pathogenesis, regardless of sporadic or familiar AD, which ultimately results in neurodegeneration [5, 6, 12].”
BackgroundAhmed, R., Huang, J., Weber, D. K., Gopinath, T., Veglia, G., Akimoto, M., Khondker, A., Rheinstädter, M. C., Huynh, V., Wylie, R. G., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01894 · Cited by 28
Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
Xi, Y., Chen, Y., Jin, Y., Han, G., Song, M., Song, T., Shi, Y., Tao, L., Huang, Z., Zhou, J., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.034 · Cited by 27
Asiatic acid and its derivatives: Pharmacological insights and applications
Liang, C., Ma, Y., Ding, M., Gao, F., Yu, K., Wang, S., Qu, Y., Hu, X., & Li, D. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117429 · Cited by 33
Fu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., & Liu, B. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100053 · Cited by 34
Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies
Ivanova, A. V., Kutuzova, A. D., Kuzmichev, I., & Abakumov, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199444 · Cited by 35
Oren, O., Ben-Zichri, S., Taube, R., Jelinek, R., & Papo, N. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00638 · Cited by 27
Lorenzi, E. D., Franceschini, D., Contardi, C., Martino, R. M. C. D., Seghetti, F., Serra, M., Bisceglia, F., Pagetta, A., Zusso, M., & Belluti, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084381 · Cited by 28
“Since Aβ oligomers are heterogeneous populations of polymorphic and non-covalent aggregates, their study is complicated and often leads to controversial results [12,50].”
ResultCerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Mirzaie, A., Nasrollahpour, H., Khalilzadeh, B., Jamali, A. A., Spiteri, R. J., Yousefi, H., Işıldak, İ., & Rahbarghazi, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117174 · Cited by 31
Designing multi-target-directed flavonoids: a strategic approach to Alzheimer's disease
Park, S., Kim, M., Lin, Y., Hong, M., Nam, G., Mieczkowski, A., Kardos, J., Lee, Y., & Lim, M. H. (2023) · Chemical Science · doi:10.1039/d3sc00752a · Cited by 28
Self-citationThe Effects of A21G Mutation on Transmembrane Amyloid Beta (11–40) Trimer: An In Silico Study
Ngô, S. T., Nguyen, M. T., Nguyen, N. T., & Vu, V. V. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b05906 · Cited by 26
Li, C., Liu, Y., Han, Y., & Wang, X. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111518 · Cited by 27
Protein Oligomer Engineering: A New Frontier for Studying Protein Structure, Function, and Toxicity
Liu, C., & Luo, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202216480 · Cited by 29
Khan, H. Y., Ahmad, A., Hassan, M. N., Khan, Y. H., Arjmand, F., & Khan, R. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215580 · Cited by 32
Pan, I., Umapathy, S., Issac, P. K., Rahman, M. M., Guru, A., & Arockiaraj, J. (2023) · Environmental Monitoring and Assessment · doi:10.1007/s10661-023-11890-7 · Cited by 29
“This enhanced electron density can improve the electrostatic attraction which efficiently enhanced the rate of OTC adsorption on PS-MP (Chen et al., 2018; Guo et al., 2012).”
BackgroundFang, S., Zhang, K., Liu, D., Yang, Y., Hu, X., Xie, W., Diao, K., Rao, Z., Wang, D., & Yang, W. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1408620 · Cited by 29
“Due to the metastability and heterogeneity of A β (mainly A β 42 ) aggregates, the pathogenesis of A β is inevitably diverse and complex (7, 8).”
BackgroundVersatile near-infrared fluorescent probe for in vivo detection of Aβ oligomers
Zeng, F., Yang, J., Li, X., Peng, K., Ran, C., Xu, Y., & Li, Y. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115559 · Cited by 25
Han, J., Yoon, J., Shin, J., Nam, E., Qian, T., Li, Y., Park, K., Lee, S., & Lim, M. H. (2022) · Nature Chemistry · doi:10.1038/s41557-022-00984-3 · Cited by 29
“A β species can interact with cell membranes and, consequently, cause cytotoxicity through multiple pathways such as blocking cellular receptors and forming ion channels 11,13–15 , 52 .”
Self-citationAlzheimer’s Disease Immunotherapy: Current Strategies and Future Prospects
Aljassabi, A., Zieneldien, T., Kim, J., Regmi, D., & Cao, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231163 · Cited by 31
“There is increasing evidence that soluble oligomers of A (cid:2) are associated better with clinical symptoms and are noticeably more neurotoxic than fibrillary aggregates [132].”
Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease
Gonçalves, P. B., Sodero, A. C. R., & Cordeiro, Y. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116684 · Cited by 27
Bhattacharya, S., Xu, L., & Thompson, D. (2018) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1359 · Cited by 22
Confer, M. P., Holcombe, B., Foes, A., Holmquist, J. M., Walker, S. C., Deb, S., & Ghosh, A. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c02306 · Cited by 21
So, K., Li, A., Liang, Y., Zhang, L., Luo, X., Wu, L.-L., Chen, Z.-W., Wei, G.-H., Zhang, K., Du, Z.-A., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.325012 · Cited by 30
“…pathology, oxidative stress, and inflammation, thereby compromising mitochondrial function and synaptic plasticity via diverse downstream effectors (e.g., nicotinic/GABAergic/insulin receptors, prion proteins, pro-inflammatory cytokines) (Lee et al., 2017; Mroczko et al., 2018; Reiss et al., 2018).”
BackgroundFörster, C. Y., Shityakov, S., Scheper, V., & Lenarz, T. (2022) · Biomolecules · doi:10.3390/biom12111717 · Cited by 32
Xiao, G., Chen, Q., & Zhang, X. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.10.008 · Cited by 28
A single-domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Bigi, A., Napolitano, L., Vadukul, D. M., Chiti, F., Cecchi, C., Aprile, F. A., & Cascella, R. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01361-z · Cited by 26
“In addition, two sdAbs, namely PrioAD12 against Aβ 40 and PrioAD13 against Aβ 42 [66] can detect Aβ oligomers simultaneously in the blood and retina of APP/PS1 mice before their appearance in the brain, with respect to age-matched wild-type mice controls [72].”
Kapadia, A., Patel, A., Sharma, K. K., Maurya, I. K., Singh, V., Khullar, M., & Jain, R. (2020) · RSC Advances · doi:10.1039/d0ra04788k · Cited by 22
Chien, H.-M., Lee, C.-C., & Huang, J. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158213 · Cited by 35
Qin, J., Guan, Y., Li, Z., Guo, X., Zhang, M., Wang, D., & Tang, J. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01499h · Cited by 23
Metadata
- Authors
- Lee, S. J. C., Nam, E., Lee, H. J., Savelieff, M. G., & Lim, M. H.
- Affiliations
- Ulsan National Institute of Science and Technology (KR)
- University of Michigan (US)
- Corresponding author
- Lim, Mi Hee
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 46
- Issue
- 2
- Pages
- 310-323
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2550762885
- Cited by
- 576
- References
- 51
- Citations by year
- 2026: 38 · 2025: 69 · 2024: 72 · 2023: 75 · 2022: 66 · 2021: 78 · 2020: 60 · 2019: 54 · 2018: 45 · 2017: 18
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, amyloid-beta aggregation, amyloid fibril formation, amyloidosis, amyloid-beta clearance
- MeSH terms
- Alzheimer Disease, Humans, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.